An Ischemic Diabetic Eye Treated with Intravenous Prostaglandin E1
| Autor: | Gianni Belcaro, Robert D Steigerwalt, Marcella Nebbioso, Antonella Pascarella, M. Rosaria Cesarone, Mauro De Angelis |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male medicine.medical_specialty Visual acuity genetic structures Vasodilator Agents Glaucoma Microcirculation Optic neuropathy chemistry.chemical_compound diabetic retinopathy glaucoma ocular ischemia pge1 prostaglandin e1 Ophthalmology medicine Humans Optic Neuropathy Ischemic Alprostadil Prostaglandin E1 Diabetic Retinopathy business.industry General Medicine Blood flow Diabetic retinopathy medicine.disease eye diseases Treatment Outcome chemistry Injections Intravenous Decreased Visual Acuity sense organs medicine.symptom business |
| Zdroj: | Scopus-Elsevier |
| Popis: | Purpose To present the use of intravenous prostaglandin E1 (PGE1), a powerful vasodilator of the microcirculation, in the treatment of an ischemic diabetic eye. Methods A 27-year-old diabetic man with ischemic diabetic retinopathy and glaucoma had a decreased visual acuity of no light perception in his right eye and hand motions in his left eye. He was started on intravenous PGE1 and has been treated for over 4.5 years. Results The visual acuity in his right eye remained unchanged and in his left eye improved gradually to 1.5/30. He has been stable for 4.5 years. Conclusion Intravenous PGE1 may be useful in ischemic diabetic eyes to improve the ocular blood flow and visual acuity. It is safe and tolerated well. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|